Contact us (+ 7 (921) 446-25-10)
Texting is available for authorized users.
Please register or log in at the website.
Your request for online training has been sent. Cbonds managers will be in touch with you shortly. Thank you!

New bond issue: Teva Pharmaceutical Industries issued international bonds (XS1789456024) with a 4.5% coupon for EUR 900.0m maturing in 2025

March 09, 2018 | Cbonds

March 07, 2018 Teva Pharmaceutical Industries issued international bonds (XS1789456024) with a 4.5% for EUR 900.0m maturing in 2025. Bonds were sold at a price of 100%. Bookrunner: Barclays, BNP Paribas, Citigroup, Credit Suisse, HSBC, Bank of America Merrill Lynch. Depository: Clearstream Banking S.A., Euroclear Bank.

Issue: Teva Pharmaceutical Industries, 4.5% 1mar2025, EUR

StatusCountry of riskRedemption (offer)VolumeIssue Rating (M/S&P/F)
outstandingIsrael03/01/20252,200,000 EURBB/Ba2/BB

Company: Teva Pharmaceutical Industries

Full company nameTeva Pharmaceutical Industries Limited
Country of riskIsrael
Country of registrationIsrael


Similar news:
Cbonds is a global fixed income data platform
  • Cbonds is a global data platform on bond market
  • Coverage: more than 170 countries and 250,000 domestic and international bonds
  • Various ways to get data: descriptive data and bond prices - website, xls add-in, mobile app
  • Analytical functionality: bond market screener, Watchlist, market maps and other tools